Your browser doesn't support javascript.
loading
Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma.
Sanegre, Sabina; Eritja, Núria; de Andrea, Carlos; Diaz-Martin, Juan; Diaz-Lagares, Ángel; Jácome, María Amalia; Salguero-Aranda, Carmen; García Ros, David; Davidson, Ben; Lopez, Rafel; Melero, Ignacio; Navarro, Samuel; Ramon Y Cajal, Santiago; de Alava, Enrique; Matias-Guiu, Xavier; Noguera, Rosa.
Affiliation
  • Sanegre S; Cancer CIBER (CIBERONC), Madrid, Spain.
  • Eritja N; Department of Pathology, School of Medical, University of Valencia-INCLIVA, Valencia, Spain.
  • de Andrea C; Cancer CIBER (CIBERONC), Madrid, Spain.
  • Diaz-Martin J; Institut de Recerca Biomèdica de LLeida (IRBLLEIDA), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Pathology, Hospital U Arnau de Vilanova and Hospital U de Bellvitge, University of Lleida - University of Barcelona, Barcelona, Spain.
  • Diaz-Lagares Á; Cancer CIBER (CIBERONC), Madrid, Spain.
  • Jácome MA; Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
  • Salguero-Aranda C; Cancer CIBER (CIBERONC), Madrid, Spain.
  • García Ros D; Institute of Biomedicine of Sevilla, Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • Davidson B; Cancer CIBER (CIBERONC), Madrid, Spain.
  • Lopez R; Cancer Epigenomics, Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago (IDIS), University Clinical Hospital of Santiago (CHUS/SERGAS), Santiago de Compostela, Spain.
  • Melero I; Department of Mathematics, MODES Group, CITIC, Faculty of Science, Universidade da Coruña, A Coruña, Spain.
  • Navarro S; Cancer CIBER (CIBERONC), Madrid, Spain.
  • Ramon Y Cajal S; Institute of Biomedicine of Sevilla, Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
  • de Alava E; Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain.
  • Matias-Guiu X; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Noguera R; Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Front Cell Dev Biol ; 9: 670185, 2021.
Article de En | MEDLINE | ID: mdl-34150764
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Front Cell Dev Biol Année: 2021 Type de document: Article Pays d'affiliation: Espagne Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Front Cell Dev Biol Année: 2021 Type de document: Article Pays d'affiliation: Espagne Pays de publication: Suisse